Pfizer Using Idun Purchase As Model For Future M&A

Pfizer is using its acquisition of Idun Pharmaceuticals as a new model for how it looks at M&A: allowing acquired companies to operate independently of Pfizer's big pharma machine

More from Archive

More from Pink Sheet